Business
Germany recommends against giving Oxford-AstraZeneca vaccine to over 65s – Sydney Morning Herald
The country’s vaccine committee says there is not enough trial data available for the age group. Australia says it trusts the TGA’s assessment.
The experts endorsed the vaccines rollout for people aged 18 to 64.
The European Unions drug regulator, the European Medicines Agency, will hand down its verdict on the vaccine on Friday.
Australia has rights to 53.8 million doses of the vaccine developed by AstraZeneca and the University of Oxford, representing the bulk of its initial portfolio.
The Australian Therapeutic Goods Administration has also been scrutinising AstraZenecas trial data ahead of an expected decision in February on whether…
-
Business14 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts
-
Noosa News13 hours agoSwimmers rescued | Noosa Today